# Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients

> **NCT00386529** · PHASE4 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 191 (actual)

## Conditions studied

- Well-controlled Hypertension

## Interventions

- **DRUG:** Aspirin enteric coated pellests 100mg

## Key facts

- **NCT ID:** NCT00386529
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-01
- **Final completion:** 2008-08
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2010-12-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00386529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00386529, "Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00386529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*